About Sotera Health

Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.

News Releases

12 Aug '21
Q2 2021 net revenues of $252 million increased approximately 18%, compared to Q2 2020 Q2 2021 net income of $43 million or $0.15 per diluted share, compared to net income of $7 million or $0.03 per diluted share in Q2 2020 Q2 2021 Adjusted EBITDA of $135 million increased approximately 18%,
12 Jul '21
CLEVELAND, July 12, 2021 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the
13 May '21
Q1 2021 net revenues of $212 million increased 13%, compared to Q1 2020 Q1 2021 net income of $11 million or $0.04 per diluted share, compared to a net loss of $2 million or $0.01 per diluted share in Q1 2020; Q1 2021 includes $14 million of expense related to the repricing of the Company’s Term

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.